MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5858/arpa.2014-0534-oa

Медицинская библиотека · Archives of pathology & laboratory medicine · 2015

The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment.

Yu Miao Crystal, Austin R Marshall, Lin Jeff, Beck Tiffany, Beriwal Sushil, Comerci John T, Edwards Robert P, Sukumvanich Paniti, Kelley Joseph, Olawaiye Alexander B

СтатьяПеревод пока не подготовлен

Аннотация

CONTEXT: Cervical cancer affects 12 000 women in the United States annually. However, despite its prevalence, there remains no good methodology to detect its recurrence.

OBJECTIVE

To identify the role of cervicovaginal high-risk human papilloma virus (hr-HPV) testing in predicting cervical cancer recurrence.

DESIGN

This is a retrospective study of patients who underwent hr-HPV testing as part of their routine surveillance for cervical cancer. Standard statistical analyses, including χ² test and multivariable logistic regression, were performed with IBM SPSS 19.0.

RESULTS

A total of 133 patients were identified, of whom 107 (80%) had squamous cell carcinoma. Ninety patients (68%) had bulky disease and were treated primarily with chemoradiation and brachytherapy. Of patients whose disease recurred, 5 patients (42%) had tested positive for hr-HPV during their surveillance period, compared to 13 patients (11%) for whom disease did not recur (relative risk: 3.88, P = .002). On multivariate logistic regression, hr-HPV status remained significantly predictive of disease recurrence (odds ratio: 12.3, P = .02, 95% confidence interval: 1.5-99.6). Using 2 × 2 table analysis, we found that while cervicovaginal cytology has limited specificity (5.7%) in predicting recurrence, the combination of cytology with hr-HPV testing increases the specificity of testing to 89.3%.

CONCLUSIONS

Persistence of hr-HPV is a risk factor for disease recurrence. High-risk-HPV testing is not routinely used during surveillance for cervical cancer, but this study suggests that large, prospective trials investigating the role of hr-HPV testing in cervical cancer surveillance are needed.

Для цитирования: Yu Miao Crystal, Austin R Marshall, Lin Jeff, Beck Tiffany, Beriwal Sushil, Comerci John T, Edwards Robert P, Sukumvanich Paniti, Kelley Joseph, Olawaiye Alexander B. The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment.. Archives of pathology & laboratory medicine. 2015. DOI: 10.5858/arpa.2014-0534-oa.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.